Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
BMC Cancer. 2023 Oct 23;23(1):1017. doi: 10.1186/s12885-023-11485-y.
BMC Cancer. 2023.
PMID: 37867191
Free PMC article.
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma.
Xiang YJ, Wang K, Yu HM, Li XW, Cheng YQ, Wang WJ, Feng JK, Bo MH, Qin YY, Zheng YT, Shan YF, Zhou LP, Zhai J, Cheng SQ.
Xiang YJ, et al.
Hepatol Res. 2022 Aug;52(8):721-729. doi: 10.1111/hepr.13773. Epub 2022 May 22.
Hepatol Res. 2022.
PMID: 35536197
Item in Clipboard
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy.
Wang K, Xiang Y, Yan J, Zhu Y, Chen H, Yu H, Cheng Y, Li X, Dong W, Ji Y, Li J, Xie D, Lau WY, Yao J, Cheng S.
Wang K, et al.
Hepatol Int. 2022 Oct;16(5):1188-1198. doi: 10.1007/s12072-022-10393-w. Epub 2022 Aug 24.
Hepatol Int. 2022.
PMID: 36001229
Item in Clipboard
Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study.
Xiang YJ, Wang K, Yu HM, Wang MM, Li LQ, Sun HC, Wen TF, Zhang YQ, Shan YF, Zhou LP, Cheng SQ.
Xiang YJ, et al.
Hepatol Res. 2022 Nov;52(11):947-956. doi: 10.1111/hepr.13811. Epub 2022 Aug 16.
Hepatol Res. 2022.
PMID: 35839151
Item in Clipboard
Cite
Cite